Postmenopausal Osteoporosis

Publisher Website
Google Scholar
Abstract
Eleven menopausal patients were treated for 12 to 18 months with low-dose sodium fluoride and calcium. Six patients also recieved estrogen replacement. A significant increase in spine or hip bone mineral density measured by dual photon absorptiometery was observed in all patients. The estrogen-treated group had the greatest increase in bone density. Addition of estrogen seems to supplement bone gain and allow sodium fluoride to be administered in lower doses, which are easily tolerated and yet effective.